The KEMRI/CDC Research and Public Health Collaboration is a sophisticated and comprehensive platform for service delivery and scientific study. Researchers measure the impact, effectiveness and safety of interventions and service delivery. We work together to innovate health care.
In 1979 the US Centers for Disease Control and Prevention (CDC) and the Kenya Medical Research Institute (KEMRI) established a partnership called the KEMRI/CDC Research and Public Health Collaboration to focus on malaria research. The collaboration has expanded its mission and staffing to become a comprehensive research platform with projects and studies located throughout Kenya. KEMRI/CDC’s work now includes research on HIV, TB, emerging infections, neglected tropical diseases and other public health issues.
The collaboration includes support for HIV prevention and care programs and a state-of-the-art health and demographic surveillance system (HDSS) and other population-based platforms to assess disease burden, disease outbreaks and health intervention impact in communities.
A key element of the KEMRI/CDC Research and Public Health Collaboration is the Health and Demographic Surveillance System. Within the geographically defined area of the HDSS, scientists studying health-related issues are able to precisely monitor and measure interventions and their health impact. The HDSS collects data from 225,061 persons in 385 villages, in Nyanza Province, every
Global Disease Detection (GDD)’s integrated approach to disease detection and response reduces the time it takes to identify and control public health risks. GDD works to help Kenya and the region detect and respond to serious public health threats like cholera, Ebola, influenza, Rift Valley fever, polio and typhoid. GDD also runs two population-based disease surveillance platforms: one in rural western Kenya and one in Kibera, an influenza program, an animal-human health program and a refugee health program. GDD also manages the Field Epidemiology and Laboratory Training Program and a laboratory science program.
HIV research conducted at KEMRI/CDC focuses on evaluating new tools to prevent the spread of the epidemic and improve the health of persons already infected with HIV. Results from the HIV research branch are ground-breaking and have influenced health care policy both in Kenya and around the world.
Malaria research at KEMRI/CDC focuses on case management and prevention and monitoring and evaluating interventions such as vaccines and insecticide-treated nets (ITNs). Studies on malaria among pregnant women (IPTp) are ongoing and assess the effectiveness of currently recommended and new drugs used for prevention and treatment. Malaria research conducted at KEMRI/CDC has had a crucial influence on national and international malaria prevention and treatment policy.
The KEMRI/CDC HISS branch reduces the impact of the HIV epidemic by providing HIV prevention such as counseling and testing, youth programs, prevention of mother to child transmission services, and care and treatment services. HISS studies how these HIV-related services are implemented, what their impact is, and evaluates best practices to determine what needs to be improved.
To measure the TB burden in Kenya and to help foster new and creative ways of preventing and treating the disease, KEMRI/CDC works with local communities and GoK to innovate service delivery to vulnerable communities. TB staff and labs are equipped and prepared to test new diagnostics, vaccine candidates and new treatment regimens once they become available.
Research at the NTD branch is focused on understanding the immunology, geographic distribution and prevalence of neglected tropical diseases as well as to studying their impact on co-infections with other illnesses like TB and HIV and in so doing develop control strategies for affected communities.